Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
Park Ha Biological Technology Co., Ltd. develops and manufactures biopharmaceutical products, utilizing advanced biological and genetic technologies. The company focuses on creating innovative solutions in the fields of healthcare and pharmaceuticals, aiming to improve patient outcomes through its research and development efforts.
Company News
INVESTOR ALERT: Morris Kandinov LLP Investigating PHH, WAI, PCLA, and EPWK; Stockholders are Encouraged to Contact the Firm
Law firm investigating potential pump-and-dump schemes involving multiple securities, with scammers using WhatsApp groups and fraudulent social media ads to solicit victims.